Kevin Patrick Lynch
No más puestos en curso
Fortuna: - $ al 31/03/2024
Perfil
Kevin Patrick Lynch worked as a Vice President at Celgene Corp.
from 2011 to 2019.
He also worked as a Medical Director-Oncology at Novartis Pharmaceuticals Australia Pty Ltd.
and as an Executive Director & Chief Medical Officer at Antengene Corp.
Ltd.
in 2021.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
16/12/2022 | 0 ( -.--% ) | - $ | 31/03/2024 |
Antiguos cargos conocidos de Kevin Patrick Lynch.
Empresas | Cargo | Fin |
---|---|---|
ANTENGENE CORPORATION LIMITED | Chief Tech/Sci/R&D Officer | 16/12/2022 |
CELGENE | Corporate Officer/Principal | 01/01/2019 |
Novartis Pharmaceuticals Australia Pty Ltd.
Novartis Pharmaceuticals Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals Australia Pty Ltd. is a private company based in Sydney, Australia. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ANTENGENE CORPORATION LIMITED | Health Technology |
Empresas privadas | 2 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Novartis Pharmaceuticals Australia Pty Ltd.
Novartis Pharmaceuticals Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals Australia Pty Ltd. is a private company based in Sydney, Australia. | Health Technology |
- Bolsa de valores
- Insiders
- Kevin Patrick Lynch